Skip to main content

Hypercalcaemia caused by a carcinoid tumour

Buy Article:

$43.00 plus tax (Refund Policy)

Humoral hypercalcaemia resulting from carcinoid tumours is uncommon. We report a case of hypercalcaemia because of excessive secretion of parathyroid hormone‐related protein (PTHrP) in a 77‐year‐old woman with an advanced carcinoid tumour. Fibroblast growth factor 23 levels were also elevated. The hypercalcaemia responded to adjunctive therapy with long‐acting octreotide analogue therapy, bisphosphonates and steroids. The role of PTHrP in humoral hypercalcaemia of malignancy, its association with neuroendocrine tumours, as well as the therapeutic use of somatostatin analogues are reviewed.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: fibroblast growth factor 23; humoral hypercalcaemia; neuroendocrine tumours; parathyroid hormoneā€related protein; somatostatin analogues

Document Type: Research Article

Affiliations: Department of Endocrinology, Waikato Hospital, Hamilton, New Zealand

Publication date: 2009-06-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more